Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin’s Lymphoma
Condition(s):Leukemia; Lymphoma, Non-HodgkinLast Updated:December 2, 2017Completed
Hide Studies Not Open or Pending
Condition(s):Leukemia; Lymphoma, Non-HodgkinLast Updated:December 2, 2017Completed
Condition(s):Advanced Adenocarcinoma of the Colon or RectumLast Updated:February 27, 2014Withdrawn
Condition(s):HIV; HypercholesterolaemiaLast Updated:October 20, 2020Completed
Condition(s):HealthyLast Updated:March 27, 2020Unknown status
Condition(s):Acute Coronary SyndromeLast Updated:December 13, 2011Unknown status
Condition(s):Atherosclerotic Cardiovascular DiseaseLast Updated:February 28, 2024Recruiting
Condition(s):Ischemia Reperfusion Injury; Cardiovascular DiseaseLast Updated:March 17, 2009Completed
Condition(s):Type 1 DiabetesLast Updated:March 13, 2017Completed
Condition(s):Pediatric Heterozygous HypercholesterolemiaLast Updated:March 15, 2021Completed
Condition(s):Stable Chronic Kidney Disease; HypertensionLast Updated:December 9, 2010Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.